p63 and p73 in human cancer: defining the network
- PMID: 17334395
- DOI: 10.1038/sj.onc.1210337
p63 and p73 in human cancer: defining the network
Abstract
The p53-related genes p63 and p73 exhibit significant structural homology to p53; however, they do not function as classical tumor suppressors and are rarely mutated in human cancers. Both p63 and p73 exhibit tissue-specific roles in normal development and a complex contribution to tumorigenesis that is due to their expression as multiple protein isoforms. The predominant p63/p73 isoforms expressed both in normal development and in many tumors lack the conserved transactivation (TA) domain; these isoforms instead exhibit a truncated N-terminus (DeltaN) and function at least in part as transcriptional repressors. p63 and p73 isoforms are regulated through both transcriptional and post-translational mechanisms, and they in turn regulate diverse cellular functions including proliferation, survival and differentiation. The net effect of p63/p73 expression in a given context depends on the ratio of TA/DeltaN isoforms expressed, on physical interaction between p63 and p73 isoforms, and on functional interactions with p53 at the promoters of specific downstream target genes. These multifaceted interactions occur in diverse ways in tumor-specific contexts, demonstrating a functional 'p53 family network' in human tumorigenesis. Understanding the regulation and mechanistic contributions of p63 and p73 in human cancers may ultimately provide new therapeutic opportunities for a variety of these diseases.
Similar articles
-
One, two, three--p53, p63, p73 and chemosensitivity.Drug Resist Updat. 2006 Dec;9(6):288-306. doi: 10.1016/j.drup.2007.01.001. Epub 2007 Feb 6. Drug Resist Updat. 2006. PMID: 17287142 Review.
-
p63 and p73 isoform expression in non-small cell lung cancer and corresponding morphological normal lung tissue.J Thorac Oncol. 2011 Mar;6(3):473-81. doi: 10.1097/JTO.0b013e31820b86b0. J Thorac Oncol. 2011. PMID: 21289519
-
Alterations of p63 and p73 in human cancers.Subcell Biochem. 2014;85:17-40. doi: 10.1007/978-94-017-9211-0_2. Subcell Biochem. 2014. PMID: 25201187 Free PMC article. Review.
-
p73, a sophisticated p53 family member in the cancer world.Cancer Sci. 2005 Nov;96(11):729-37. doi: 10.1111/j.1349-7006.2005.00116.x. Cancer Sci. 2005. PMID: 16271066 Free PMC article. Review.
-
The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network.Cancer Metastasis Rev. 2010 Dec;29(4):613-39. doi: 10.1007/s10555-010-9257-9. Cancer Metastasis Rev. 2010. PMID: 20922462 Review.
Cited by
-
FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma.J Clin Invest. 2013 Aug;123(8):3525-38. doi: 10.1172/JCI68899. Epub 2013 Jul 8. J Clin Invest. 2013. PMID: 23867503 Free PMC article.
-
The chromosomal instability pathway in colon cancer.Gastroenterology. 2010 Jun;138(6):2059-72. doi: 10.1053/j.gastro.2009.12.065. Gastroenterology. 2010. PMID: 20420946 Free PMC article. Review.
-
Smurfs in Protein Homeostasis, Signaling, and Cancer.Front Oncol. 2018 Aug 2;8:295. doi: 10.3389/fonc.2018.00295. eCollection 2018. Front Oncol. 2018. PMID: 30116722 Free PMC article. Review.
-
Melanoma cells resistant towards MAPK inhibitors exhibit reduced TAp73 expression mediating enhanced sensitivity to platinum-based drugs.Cell Death Dis. 2018 Sep 11;9(9):930. doi: 10.1038/s41419-018-0952-8. Cell Death Dis. 2018. PMID: 30206212 Free PMC article.
-
Discovery of a potent cytotoxic agent that promotes G2/M phase cell cycle arrest and apoptosis in a malignant human pharyngeal squamous carcinoma cell line.Int J Oncol. 2022 Apr;60(4):41. doi: 10.3892/ijo.2022.5331. Epub 2022 Feb 25. Int J Oncol. 2022. PMID: 35211767 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous